• Galcanezumab Looks Promising For Treatment-Resistant Migraine

    1 month ago - By Medscape

    The calcitonin gene-related peptide monoclonal antibody compared favorably to placebo for reducing the number of average monthly migraine days in a study of people with treatment-resistant migraine.
    Medscape Medical News
    Read more ...